MDNAF (Medicenna Therapeutics) Cyclically Adjusted Book per Share: $0.36 (As of Mar. 2026)


MDNAF Medicenna Therapeutics Corp MDNAF
29 GF Score
Price $0.28
! 1 Warning Sign
View Full Analysis

What is Medicenna Therapeutics Cyclically Adjusted Book per Share?

Medicenna Therapeutics MDNAF -8.64% 29 Cyclically Adjusted Book per Share is $0.36 as of Mar. 2026. GuruFocus rates MDNAF with a GF Score™ of 29/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medicenna Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was $0.022. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.36 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medicenna Therapeutics's average Cyclically Adjusted Book Growth Rate was -19.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-03), Medicenna Therapeutics's current stock price is $0.275. Medicenna Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.36. Medicenna Therapeutics's Cyclically Adjusted PB Ratio of today is 0.76.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Medicenna Therapeutics was 0.78. The lowest was 0.00. And the median was 0.00.


Medicenna Therapeutics  (OTCPK:MDNAF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medicenna Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.275/0.36
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Medicenna Therapeutics was 0.78. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medicenna Therapeutics Cyclically Adjusted Book per Share Related Terms


Medicenna Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medicenna Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicenna Therapeutics Cyclically Adjusted Book per Share Chart

Medicenna Therapeutics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.43 0.36

Medicenna Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.45 0.43 0.41 0.36

MDNAF vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Medicenna Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicenna Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medicenna Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medicenna Therapeutics's Cyclically Adjusted PB Ratio falls into.


MDNAF
29GF Score
Medicenna Therapeutics Corp MDNAF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicenna Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicenna Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.022/132.2600*132.2600
=0.022

Current CPI (Mar. 2026) = 132.2600.

Medicenna Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.582 102.002 0.755
201609 0.560 101.765 0.728
201612 3.132 101.449 4.083
201703 0.205 102.634 0.264
201706 0.151 103.029 0.194
201709 0.120 103.345 0.154
201712 0.074 103.345 0.095
201803 0.068 105.004 0.086
201806 0.051 105.557 0.064
201809 0.039 105.636 0.049
201812 0.091 105.399 0.114
201903 0.068 106.979 0.084
201906 0.046 107.690 0.056
201909 0.005 107.611 0.006
201912 0.116 107.769 0.142
202003 0.553 107.927 0.678
202006 0.595 108.401 0.726
202009 0.555 108.164 0.679
202012 0.503 108.559 0.613
202103 0.567 110.298 0.680
202106 0.495 111.720 0.586
202109 0.362 112.905 0.424
202112 0.334 113.774 0.388
202203 0.296 117.646 0.333
202206 0.250 120.806 0.274
202209 0.365 120.648 0.400
202212 0.351 120.964 0.384
202303 0.309 122.702 0.333
202306 0.291 124.203 0.310
202309 0.249 125.230 0.263
202312 0.199 125.072 0.210
202403 0.055 126.258 0.058
202406 0.218 127.522 0.226
202409 0.192 127.285 0.200
202412 0.157 127.364 0.163
202503 0.170 129.181 0.174
202506 0.128 129.892 0.130
202509 0.089 130.290 0.090
202512 0.054 130.370 0.055
202603 0.022 132.260 0.022

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.36 mean?
Medicenna Therapeutics (MDNAF) has a Cyclically Adjusted Book per Share of $0.36 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medicenna Therapeutics and its competitors.
Is Medicenna Therapeutics' Cyclically Adjusted Book per Share too high?
Medicenna Therapeutics' current Cyclically Adjusted Book per Share is $0.36. Overall, Medicenna Therapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Medicenna Therapeutics' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Medicenna Therapeutics' Cyclically Adjusted Book per Share of $0.36 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medicenna Therapeutics and its competitors. Medicenna Therapeutics's current Cyclically Adjusted Book per Share is $0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicenna Therapeutics stock overvalued right now?
Medicenna Therapeutics (MDNAF) has a current Cyclically Adjusted Book per Share of $0.36. The current Cyclically Adjusted Book per Share is $0.36. Medicenna Therapeutics' overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medicenna Therapeutics (MDNAF), the current Cyclically Adjusted Book per Share is $0.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicenna Therapeutics Business Description

Other Exchanges MDNA:Canada
Address 2 Bloor Street West, Suite 903, Toronto, ON, CAN, M4W 3E2
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL-13 Superkines and Empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. Its pipeline candidates include MDNA11 for Cancer immunotherapies, MDNA55 is a Molecular Trojan Horse, and BiSKITs represent a novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
29GF Score

Get the complete analysis for MDNAF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price